SII
- India
Notices issued to Centre, Bill Gates, SII over plea on alleged COVID vaccine death
Mumbai: The Bombay High Court issued notices to the Government of India, Serum Institute of India (SII), Microsoft founder Bill Gates, All India Institute of Medical Science Director, DCGI chief and others…
- India
DCGI to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today
New Delhi: Drugs Controller General of India (DCGI)’s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively…
- India
Adar Poonawalla sets aside Rs 10 cr to support students travelling abroad
New Delhi: Serum Institute of India CEO and owner Adar Poonawalla on Thursday said that he has set aside Rs 10 crore to support students travelling abroad for studies, as a few countries…
- World
France allows visitors with India’s Covishield
Paris: France will allow international travellers who have had AstraZeneca’s Indian-manufactured vaccine into the country starting Sunday. At the same time, France is tightening border checks to control the spread of the delta…
- India
SII starts production of Covovax, CEO says it has ‘great potential’ for children
In a new move towards ensuring better inoculation, the Serum Institute of India (SII) has started the production of the first batch of the Novavax COVID-19 vaccine in India, dubbed Covovax. Novavax…
- India
COVID-19 vaccine manufacturers bag huge profits on ‘humanitarian’ cause: Report
Hyderabad: 2.9 crore cases and 3.85 lakh deaths since the pandemic began in March 2020 and India’s vaccine makers have turned out to be classic profiteers instead of the humanitarians that they…
- World
SII partner Novavax’s COVID-19 shot 90% effective
Washington: US-based biotechnology company Novavax’s protein-based vaccine has shown overall 90 per cent efficacy against Covid-19, results of Phase-3 trials have shown. The vaccine NVX-CoV2373 is already being locally manufactured by the company’s…
- India
Halt in exports by SII leaves global vaccination drive stumbling
The Serum Institute of India, and with it India, has snagged the title of the largest vaccine manufacturer in the world. But as the second wave hit the country and left people…
- India
Serum Institute applies to manufacture COVID vaccine Sputnik V
New Delhi: The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said on Thursday.…
- Business
India’s Serum Institute to invest £240 million in UK
London: The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing…
- India
Powerful Indians making aggressive calls for vaccines: Poonawalla
London: Admitting that he is facing immense pressure from “some of the most powerful people in India” demanding supplies of Covishield, Serum Institute of India (SII) CEO Adar Poonawalla said on Saturday that…
- India
Bharat Biotech’s announcement to spark debate on COVID-19 vax pricing
Hyderabad: Bharat Biotech’s pricing announcement of its COVID-19 vaccine, Covaxin on Saturday is likely to further intensify the debate on pricing as the critics have slammed both the vaccine manufacturers for ‘profiteering’. However,…
- India
SII breaks silence, calls Covishield most affordable jab
New Delhi: The Serum Institute of India (SII) on Saturday broke its silence over the pricing of its COVID-19 vaccine ‘Covishield’ and said that it is the most affordable vaccine available in the…
- India
Vaccine policy discriminatory, reverse it: Sonia Gandhi to PM
New Delhi: Congress president Sonia Gandhi on Thursday wrote to Prime Minister Narendra Modi over the new COVID-19 vaccine policy, terming it as arbitrary and discriminatory and urged him to intervene immediately to…
- India
SII hikes Covishield vaccine prices, to cost between Rs 400-600
Hyderabad: Two days after the central government announced a “liberalized and accelerated” vaccination drive from May 1, the Serum Institute of India on Wednesday announced the prices for Covishield (AstraZeneca, the vaccine…
